Combination of sulindac and eflornithine delays the need for lower gastrointestinal surgery in patients with familial adenomatous polyposis: Post hoc analysis of a randomized clinical trial

Authors

Francesc Balaguer, University of Barcelona
Paul E Wise, Washington University School of Medicine in St. Louis
et al

Journal

Diseases of the Colon and Rectum

Publication Date

4-1-2022

Volume

65

Issue

4

First Page

536

Last Page

545

Document Type

Open Access Publication

DOI

10.1097/DCR.0000000000002095

Rights and Permissions

Balaguer F, Stoffel EM, Burke CA, Dekker E, Samadder NJ, Van Cutsem E, Lynch PM, Wise PE, Hüneburg R, Lim RM, Boytim ML, Du W, Bruckheimer EM, Cohen A, Church J; FAP-310 Investigators. Combination of Sulindac and Eflornithine Delays the Need for Lower Gastrointestinal Surgery in Patients With Familial Adenomatous Polyposis: Post Hoc Analysis of a Randomized Clinical Trial. Dis Colon Rectum. 2022 Apr 1;65(4):536-545. doi.org/10.1097/DCR.0000000000002095 This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CC BY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Recommended Citation

Balaguer, Francesc; Wise, Paul E; and et al, "Combination of sulindac and eflornithine delays the need for lower gastrointestinal surgery in patients with familial adenomatous polyposis: Post hoc analysis of a randomized clinical trial." Diseases of the Colon and Rectum. 65, 4. 536 - 545. (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11962